LANCET Pharmaceuticals

Pharmaceuticals, Pharmaceutics, Hospital market, Biopharmaceutics, Pharmaceuticals
Founded in 2005
Moscow
http://www.lancetpharm.ru
None

About LANCET Pharmaceuticals

National supplier of innovative products for diagnostics, treatment of socially significant diseases and products for subsequent rehabilitation of patients.Lancet facilitates health recovery returning patients and his family to real life. We place medicines of the best world manufacturers on the Russian and EAEU markets, make available modern diagnostic, treatment and rehabilitation methods. We strive for long-term cooperation with Ministries of Healthcare, diagnostic and treatment institutions and patients, offering customized complex solutions for their needs at each stage of treatment diagnostic process. Lancet's strength areas are: balanced pharmaceutical portfolio, efficient tendering and supply techniques as well as strong brand and high reputation on the market.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $100M to $500M
  • Total Funding: None None
  • Last Funding: None None (None)
  • Funding Status: None

Technology Stack

LANCET Pharmaceuticals actively uses None products in their tech stack.

Market Presence

Industries: Pharmaceuticals, Pharmaceutics, Hospital market, Biopharmaceutics, Pharmaceuticals

Headquarters: Moscow